Yunzhi intracellular glycopeptide capsules

1 This product can enhance the function of the reticuloendothelial system (RES) by enhancing the proliferation of monocytes and activating the function of each phagocyte. It can significantly increase the concentration of serum interferon induced by mice; it can enhance the phagocytic activity of neutrophils by activating the function of leukocytes themselves without increasing the number of leukocytes; it can promote the production of 615 mouse-specific hemolysin antibodies caused by a single SRBC immunization; it can antagonize the strong suppression of cellular immunity caused by cyclophosphamide, methotrexate, 5-FU, mitomycin C, etc., improve cellular immune function and restore it to normal. 2 For acute liver damage in rats and mice caused by D-galactosamine and carbon tetrachloride, this product can significantly inhibit the increase of SGP, the incidence of fatty changes in liver cells is lower than that of the control group, and it can completely avoid the occurrence of focal necrosis. 3 This product can make the killing rate of mouse peritoneal macrophages against Ehrlich ascites cancer cells reach 41% to 54%; it can enhance the effect of anticancer drugs; this product can also effectively inhibit tumor angiogenesis and transplanted breast cancer growth by reducing the level of growth factor TGF-beta;1. 4 This product can strongly activate the body's own defense immune system, has secondary nonspecific anti-infection and anti-shock effects, can significantly reduce the mortality caused by infection with Staphylococcus aureus, Escherichia coli, and Shigella dysenteriae, and has a significant protective effect on the death of mice caused by influenza virus infection, with a protection rate of 50% to 60%, and the average survival time can be extended by 153% to 188%.

The ingredient of this product is intracellular glycopeptide from Coriolus versicolor.

This product is a capsule, and its contents are brown or reddish brown powder or granules.

Used as an adjuvant treatment for chronic hepatitis B, liver cancer and the elderly with impaired immune function.

Oral administration: 0.5-1.0g each time, 3 times a day.

Not yet clear.

It is contraindicated for those who are allergic to this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Not yet clear.

Keep tightly closed in a cool, dry place.

0.25g

24 months

Sinopharm ChuanKang Pharmaceutical Co., Ltd.

• Founded in:

  2003-05-09

• Address:

  No. 2, Xinwen Road, West Park, Chengdu Hi-tech Zone

• Tax NO.:

  91510100749702784T

• Registered Funds:

  40 million yuan

• Website:

  Log in to view

• Email:

  Log in to view